Dimerix fast-tracks kidney drug trial via new cash raise

MELBOURNE: Dimerix will rapidly expand the phase three clinical trial of its flagship kidney drug

To read the full story...SUBSCRIBE NOW

Existing Subscribers Login Below:

Log In